Evidence map›Paper›PMID 31941707›Full record

Trial reportCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2020

Feasibility and Acceptability of a Web-Based Dietary Intervention with Text Messages for Colorectal Cancer: A Randomized Pilot Trial.

Erin L Van Blarigan, Stacey A Kenfield, June M Chan, Katherine Van Loon, Alan Paciorek, Li Zhang, Hilary Chan, Marissa B Savoie, Andrea Grace Bocobo, Vivian N Liu and 7 more

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02965521 (Survivor Choices for Eating and Drinking - Colorectal Cancer), which is not on this map. Cited by 24 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 5 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02965521 nacompletednot on this map

Survivor Choices for Eating and Drinking - Colorectal Cancer

TypeinterventionalSponsorUniversity of California, San FranciscoRan2017 to 2018Enrolled50ConditionsColon Cancer, Rectal Cancer, ColoRectal CancerArmsWebsite and text messages
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 5 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Feasibility, acceptability, and effects of behavior change interventions for improving multiple dietary behaviors among cancer survivors: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Quality of life among colorectal cancer survivors participating in a pilot randomized controlled trial of a web-based dietary intervention with text messages.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Trial
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Erin L Van BlariganDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California. erin.vanblarigan@ucsf.edu.ORCID 0000-0001-5079-3385
Stacey A KenfieldDepartment of Urology, University of California, San Francisco, San Francisco, California.
June M ChanDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.
Katherine Van LoonUCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.ORCID 0000-0002-9705-4114
Alan PaciorekUCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.ORCID 0000-0001-9749-6548
Li ZhangDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.
Hilary ChanSchool of Medicine, University of California, San Francisco, San Francisco, California.
Marissa B SavoieSchool of Medicine, University of California, San Francisco, San Francisco, California.
Andrea Grace BocoboUCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.
Vivian N LiuUniversity of California, Berkeley, Berkeley, California.
Louis X WongUCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.
Angela LaffanUCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.
Chloe E AtreyaUCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.
Christine MiaskowskiDepartment of Physiologic Nursing, University of California, San Francisco, San Francisco, California.
Yoshimi FukuokaDepartment of Physiologic Nursing, University of California, San Francisco, San Francisco, California.
Jeffrey A MeyerhardtDana-Farber Cancer Institute, Boston, Massachusetts.
Alan P VenookUCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.ORCID 0000-0001-9749-6548
University of California, San Francisco · USUCSF Helen Diller Family Comprehensive Cancer Center · USDana-Farber Cancer Institute · USUniversity of California, Berkeley · US

Funding

Impact of Celecoxib and Inflammation on Survival in Stage III Colon CancerR01CA169141 · NCI · YALE UNIVERSITY · PI FUCHS, CHARLES S · 2013 to 2018
$3.9M
Mentoring and research in applying digital technologies to prevent chronic IllnessesK24NR015812 · NINR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FUKUOKA, YOSHIMI · 2015 to 2020
$930k
Diet After Colorectal Cancer : Observational Studies to Behavioral InterventionsK07CA197077 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VAN BLARIGAN, ERIN LYNN · 2016 to 2020
$885k
NCI NIH HHS K07 CA197077NCI NIH HHS R01 CA169141NINR NIH HHS K24 NR015812
6 · The paper itself

Abstract

backgroundDiet is associated with colorectal cancer survival. Yet, adherence to nutrition guidelines is low among colorectal cancer survivors.

methodsWe conducted a pilot trial among colorectal cancer survivors to evaluate a 12-week remote dietary intervention. Participants received print materials and were randomized (1:1) to intervention (website, text messages) or wait-list control. Primary outcomes included feasibility and acceptability. We also explored change in diet from 0 to 12 and 24 weeks and change from 0 to 12 weeks in anthropometry and circulating biomarkers (Trial Registration: NCT02965521).

resultsWe randomized 50 colorectal cancer survivors (25 intervention, 25 control). Retention was 90% at 12 weeks and 84% at 24 weeks. Participants had a median age of 55 years and were 66% female, 70% non-Hispanic white, and 96% had a college degree. The intervention arm responded to a median 15 (71%) of 21 text messages that asked for a reply [interquartile range (IQR) = 8, 19] and visited the website a median of 13 (15%) days (IQR = 1, 33) of the 84 study days.

conclusionsWe developed a Web-based dietary intervention for colorectal cancer survivors. Our pilot results suggest that colorectal cancer survivors may engage more with text messages than a study website. Research to improve tailoring of text messages, while maintaining scalability, is needed. IMPACT: Remote dietary interventions using text messages may be feasible for colorectal cancer survivors.

Indexed as

Text MessagingCancer SurvivorsColorectal NeoplasmsCross-Over StudiesDiet RecordsFeasibility StudiesFemaleHumansInternet-Based InterventionMaleMiddle AgedPatient CompliancePatient ParticipationPilot ProjectsTreatment Outcome

Identifiers

PMID31941707
PMCPMC7125029
OpenAlexW2999305208

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.